-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
GlobeStar Therapeutics Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2011 to 2023.
- GlobeStar Therapeutics Corp Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$198K, a 84.6% increase year-over-year.
- GlobeStar Therapeutics Corp Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$887K, a 53.5% increase year-over-year.
- GlobeStar Therapeutics Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$1.95M, a 31% decline from 2022.
- GlobeStar Therapeutics Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$1.49M, a 84.8% increase from 2021.
- GlobeStar Therapeutics Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$9.8M, a 1709% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)